Listed

PharmaCyte Biotech, Inc.: Form 10-K for the period ended Apr 30, 2017

Filed with the SEC on Jul 27, 2017 and accepted by EDGAR at Jul 27, 2017, 17:22 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-04-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2017-02-01 to 2017-04-30$0us-gaap:Revenues
Revenue12 months2016-05-01 to 2017-04-30$0us-gaap:Revenues
Cost of revenue3 months2017-02-01 to 2017-04-30$0us-gaap:CostOfRevenue
Gross profit3 months2017-02-01 to 2017-04-30$0us-gaap:GrossProfit
Research and development12 months2016-05-01 to 2017-04-30$1.2mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2016-05-01 to 2017-04-30−$4.4mus-gaap:OperatingIncomeLoss
Interest expense12 months2016-05-01 to 2017-04-30$1.5kus-gaap:InterestExpense
Income tax12 months2016-05-01 to 2017-04-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-02-01 to 2017-04-30−$1.2mus-gaap:NetIncomeLoss
Net income12 months2016-05-01 to 2017-04-30−$4.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-02-01 to 2017-04-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS12 months2016-05-01 to 2017-04-30−$0.01us-gaap:EarningsPerShareBasicAndDiluted
Diluted shares (weighted)12 months2016-05-01 to 2017-04-30845,308,413 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Cash and equivalentsAt period end2017-04-30$3.5mus-gaap:Cash
Current assetsAt period end2017-04-30$3.5mus-gaap:AssetsCurrent
Total assetsAt period end2017-04-30$8.7mus-gaap:Assets
Current liabilitiesAt period end2017-04-30$580.2kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-04-30$580.2kus-gaap:Liabilities
Shareholders' equityAt period end2017-04-30$8.1mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001683168-17-001881. Last ingested by Listed: Nov 14, 2026, 20:52 ET. Listed shows no prices and gives no investment advice.